statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	982
SG - Singapore	250
CN - Cina	143
DE - Germania	64
BR - Brasile	56
VN - Vietnam	54
IT - Italia	43
HK - Hong Kong	39
UA - Ucraina	37
GB - Regno Unito	34
TR - Turchia	22
FI - Finlandia	18
FR - Francia	17
MX - Messico	15
BD - Bangladesh	14
CA - Canada	14
SE - Svezia	14
IN - India	11
JP - Giappone	11
RU - Federazione Russa	9
AR - Argentina	7
BE - Belgio	6
ES - Italia	5
ZA - Sudafrica	4
IR - Iran	3
PK - Pakistan	3
PL - Polonia	3
AZ - Azerbaigian	2
CO - Colombia	2
EC - Ecuador	2
JO - Giordania	2
PA - Panama	2
PH - Filippine	2
SA - Arabia Saudita	2
SI - Slovenia	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AO - Angola	1
AT - Austria	1
BW - Botswana	1
CH - Svizzera	1
CL - Cile	1
CZ - Repubblica Ceca	1
EG - Egitto	1
HN - Honduras	1
ID - Indonesia	1
IE - Irlanda	1
IQ - Iraq	1
JM - Giamaica	1
KE - Kenya	1
KW - Kuwait	1
LB - Libano	1
LT - Lituania	1
MT - Malta	1
MU - Mauritius	1
MY - Malesia	1
NP - Nepal	1
PE - Perù	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.923

Nome	#
A non-invasive method for the in vivo determination of skin antioxidant capacity	301
Novel selective human mitochondrial kinase inhibitors: Design, synthesis and enzymatic activity	231
Hindered nucleoside analogs as antiflaviviridae agents	209
Design, Synthesis and Anti Flaviviridae Activity of N 6-, 5,3-O- and 5,2-O-Substituted Adenine Nucleoside Analogs	201
Design, synthesis and binding at cloned muscarinic receptors of N-[5-(1'-substituted-acetoxymethyl)-3-oxadiazolyl] and N-[4-(1'-substituted-acetoxymethyl)-2-dioxolanyl] dialkyl amines	187
Design, Synthesis and activity of a new series of nucleoside analogues displaying potent antiflaviviridae activity.	169
Determinazione dell'efficacia antiossidante di formulazioni cosmetiche attraverso metodiche non invasive	161
Adenosine phosphonoacetic acid is slowly metabolized by NDP kinase	117
The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes	102
Ribonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates	92
null	88
Synthesis, modeling and evaluation of 3'-(1-aryl-1H-tetrazol-5-ylamino)-substituted 3'-deoxythymidine derivatives as potent and selective human mitochondrial thymidine kinase inhibitors	74
Totale	1.932

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	4	0	0	0	0	0	0	0	0	0	0	0	4
2021/2022	101	2	3	15	5	6	4	6	1	4	7	10	38
2022/2023	113	9	6	4	17	23	19	10	4	14	0	6	1
2023/2024	55	7	11	5	0	7	6	0	2	6	0	1	10
2024/2025	320	7	8	24	24	38	58	16	10	30	21	49	35
2025/2026	819	80	22	46	136	165	66	85	31	77	69	37	5
Totale													1.932

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara